BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...to get ahead of resistance at the DNA level. Swanton’s team has two therapeutic approaches. ApoGen Biotechnologies Inc....
...them.” Companies and Institutions Mentioned Achilles Therapeutics Ltd., Stevenage, U.K. Amal Therapeutics S.A., Geneva, Switzerland ApoGen Biotechnologies Inc....
...KDM5A - Lysine-specific demethylase 5A KDM5B - Lysine-specific demethylase 5B Karen Tkach Tuzman, Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer...
BioCentury | Aug 31, 2018
Financial News

ApoGen expands series A to $11M

...Drug-resistant cancer company ApoGen Biotechnologies Inc. raised an additional $4 million on Aug. 23 from M Ventures and...
...ultimately become C-to-T or C-to-G point mutations (see “Resisting Resistance” ). ApoGen Biotechnologies Inc., Seattle, Wash. Jaime De Leon ApoGen Biotechnologies Inc. Apolipoprotein...
BioCentury | Mar 30, 2017
Emerging Company Profile

Resisting resistance

...While many companies are attempting to counteract mutations in cancer that result in resistance, ApoGen Biotechnologies Inc. is...
...launch out of Accelerator. The company plans to hire research staff this year. COMPANY PROFILE ApoGen Biotechnologies Inc....
...WuXi PharmaTech Inc. CEO: None Patents: Undisclosed Companies and Institutions Mentioned Accelerator Corp., Seattle, Wash. ApoGen Biotechnologies Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...Through New York’s Accelerator Corp., JJDC participated in the $7 million series A round for ApoGen Biotechnologies Inc....
...Mentioned AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Ablexis LLC, San Francisco, Calif. Affinicon ApS, Aarhus, Denmark ApoGen Biotechnologies Inc....
BioCentury | Dec 14, 2016
Financial News

ApoGen completes venture financing

...& Johnson Innovation-JJDC, Watson Fund, WRF Capital and WuXi PharmaTech Inc. ApoGen Biotechnologies Inc. , Seattle, Wash. Alex Himes ApoGen Biotechnologies Inc....
BioCentury | Dec 13, 2016
Financial News

ApoGen debuts with $7M

...Seattle, Wash.) said it participated in a $7 million series A financing for oncology newco ApoGen Biotechnologies Inc....
Items per page:
1 - 6 of 6
BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...to get ahead of resistance at the DNA level. Swanton’s team has two therapeutic approaches. ApoGen Biotechnologies Inc....
...them.” Companies and Institutions Mentioned Achilles Therapeutics Ltd., Stevenage, U.K. Amal Therapeutics S.A., Geneva, Switzerland ApoGen Biotechnologies Inc....
...KDM5A - Lysine-specific demethylase 5A KDM5B - Lysine-specific demethylase 5B Karen Tkach Tuzman, Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer...
BioCentury | Aug 31, 2018
Financial News

ApoGen expands series A to $11M

...Drug-resistant cancer company ApoGen Biotechnologies Inc. raised an additional $4 million on Aug. 23 from M Ventures and...
...ultimately become C-to-T or C-to-G point mutations (see “Resisting Resistance” ). ApoGen Biotechnologies Inc., Seattle, Wash. Jaime De Leon ApoGen Biotechnologies Inc. Apolipoprotein...
BioCentury | Mar 30, 2017
Emerging Company Profile

Resisting resistance

...While many companies are attempting to counteract mutations in cancer that result in resistance, ApoGen Biotechnologies Inc. is...
...launch out of Accelerator. The company plans to hire research staff this year. COMPANY PROFILE ApoGen Biotechnologies Inc....
...WuXi PharmaTech Inc. CEO: None Patents: Undisclosed Companies and Institutions Mentioned Accelerator Corp., Seattle, Wash. ApoGen Biotechnologies Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...Through New York’s Accelerator Corp., JJDC participated in the $7 million series A round for ApoGen Biotechnologies Inc....
...Mentioned AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Ablexis LLC, San Francisco, Calif. Affinicon ApS, Aarhus, Denmark ApoGen Biotechnologies Inc....
BioCentury | Dec 14, 2016
Financial News

ApoGen completes venture financing

...& Johnson Innovation-JJDC, Watson Fund, WRF Capital and WuXi PharmaTech Inc. ApoGen Biotechnologies Inc. , Seattle, Wash. Alex Himes ApoGen Biotechnologies Inc....
BioCentury | Dec 13, 2016
Financial News

ApoGen debuts with $7M

...Seattle, Wash.) said it participated in a $7 million series A financing for oncology newco ApoGen Biotechnologies Inc....
Items per page:
1 - 6 of 6